These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3807648)

  • 21. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.
    Choca JI; Green RD; Proudfit HK
    J Pharmacol Exp Ther; 1988 Nov; 247(2):757-64. PubMed ID: 3183969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat.
    Correia-de-Sá P; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1991 Jun; 103(2):1614-20. PubMed ID: 1679362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic and saliuretic effects of 1,3-dipropyl-8-cyclopentylxanthine, a selective A1-adenosine receptor antagonist.
    Collis MG; Shaw G; Keddie JR
    J Pharm Pharmacol; 1991 Feb; 43(2):138-9. PubMed ID: 1672902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
    Trivedi BK; Bristol JA; Bruns RF; Haleen SJ; Steffen RP
    J Med Chem; 1988 Jan; 31(1):271-3. PubMed ID: 3336027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?
    Oguchi T; Furukawa Y; Sawaki S; Kasama M; Chiba S
    J Pharmacol Exp Ther; 1995 Feb; 272(2):838-44. PubMed ID: 7853202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activity of bamifylline on adenosine A1-receptors in rat brain.
    Abbracchio MP; Cattabeni F
    Pharmacol Res Commun; 1987 Aug; 19(8):537-45. PubMed ID: 3432321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogs.
    Porter NM; Radulovacki M; Green RD
    J Pharmacol Exp Ther; 1988 Jan; 244(1):218-25. PubMed ID: 3335999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of P1-purinoceptors on rat duodenum and urinary bladder.
    Nicholls J; Hourani SM; Kitchen I
    Br J Pharmacol; 1992 Mar; 105(3):639-42. PubMed ID: 1628151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA; Johnson RA; Wells JN
    Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitization of cardiac actions of adenosine in rats after chronic theophylline treatment.
    Lee HT; Thompson CI; Linden J; Belloni FL
    Am J Physiol; 1993 May; 264(5 Pt 2):H1634-43. PubMed ID: 8498576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
    Merkel LA; Lappe RW; Rivera LM; Cox BF; Perrone MH
    J Pharmacol Exp Ther; 1992 Feb; 260(2):437-43. PubMed ID: 1310735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro analysis of purine-mediated renal vasoconstriction in rat isolated kidney.
    Kenakin TP; Pike NB
    Br J Pharmacol; 1987 Feb; 90(2):373-81. PubMed ID: 3828655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of adenosine A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells.
    Olivera A; Tomás M; López-Novoa JM
    Am J Physiol; 1992 Apr; 262(4 Pt 1):C840-4. PubMed ID: 1314488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of propentofylline on adenosine A1 and A2 receptors and nitrobenzylthioinosine-sensitive nucleoside transporters: quantitative autoradiographic analysis.
    Parkinson FE; Fredholm BB
    Eur J Pharmacol; 1991 Sep; 202(3):361-6. PubMed ID: 1748157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological probes for A1 and A2 adenosine receptors in vivo in feline pulmonary vascular bed.
    Neely CF; Matot I
    Am J Physiol; 1996 Feb; 270(2 Pt 2):H610-9. PubMed ID: 8779837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
    Fredholm BB; Sandberg G
    Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
    J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.